Benzoic acid, 2-(cyclopentylamino)propyl ester, hydrochloride

Suppliers

Names

[ CAS No. ]:
67032-26-2

[ Name ]:
Benzoic acid, 2-(cyclopentylamino)propyl ester, hydrochloride

[Synonym ]:
Benzoesaeure-(2-cyclopentylamino-propylester),Hydrochlorid
1-Propanol,2-(cyclohexylamino)-,benzoate (ester),hydrochloride
Benzoic acid,2-(cyclohexylamino)propyl ester,hydrochloride
2-(cyclohexylamino)propyl benzoate hydrochloride(1:1)
benzoic acid-(2-cyclopentylamino-butyl ester),hydrochloride
benzoic acid-(2-cyclopentylamino-propylester),hydrochloride
Benzoesaeure-(2-cyclohexylamino-propylester),Hydrochlorid
2-Cyclohexylamino-1-propanol benzoate hydrochloride
Benzoesaeure-(2-cyclopentylamino-butylester),Hydrochlorid

Chemical & Physical Properties

[ Density]:
1.06g/cm3

[ Boiling Point ]:
369.4ºC at 760 mmHg

[ Molecular Formula ]:
C15H22ClNO2

[ Molecular Weight ]:
283.79400

[ Flash Point ]:
177.2ºC

[ Exact Mass ]:
283.13400

[ PSA ]:
38.33000

[ LogP ]:
3.95700

[ Index of Refraction ]:
1.533

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DG5790000
CHEMICAL NAME :
Benzoic acid, 2-(cyclopentylamino)propyl ester, hydrochloride
CAS REGISTRY NUMBER :
67032-26-2
LAST UPDATED :
199303
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C15-H21-N-O2.Cl-H
MOLECULAR WEIGHT :
283.83
WISWESSER LINE NOTATION :
L5TJ AMY1&1OVR &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 90,181,1947
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 90,181,1947

Related Compounds

  • N-(4-fluorophenyl)-2-((2-oxo-1-(pyridin-4-ylmethyl)-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl)thio)acetamide
  • 4-((2-oxo-2-(piperidin-1-yl)ethyl)thio)-1-(pyridin-3-ylmethyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-2(5H)-one
  • 4-((2-(indolin-1-yl)-2-oxoethyl)thio)-1-(pyridin-3-ylmethyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-2(5H)-one
  • N-(5-methylisoxazol-3-yl)-2-((2-oxo-1-(pyridin-3-ylmethyl)-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl)thio)acetamide
  • 1-[(4-methylphenyl)methyl]-2-oxo-N-(pyridin-3-yl)-1,2-dihydropyridine-3-carboxamide
  • N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide
  • Potassium (3-bromo-5-methylphenyl)trifluoroborate
  • Potassium (4-bromo-2,5-dimethylphenyl)trifluoroborate
  • (R)-3-((R)-1-Methylpyrrolidin-2-yl)piperidine
  • (2s)-1-({(2s,4s)-4-[2-(1,3-Dihydro-2h-isoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidin-2-yl}carbonyl)-4,4-difluoropyrrolidine-2-carbonitrile
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.